abarelix sold brand name plenaxis injectable gonadotropinreleasing hormone antagonist gnrh antagonist marketed germany netherlands primarily used oncology reduce amount testosterone made patients advanced symptomatic prostate cancer treatment options originally marketed praecis pharmaceuticals marketed speciality european pharma receiving marketing authorization drug introduced united states discontinued country may due poor sales higherthanexpected incidence severe allergic remains marketed germany netherlands pharmacologyrelated article stub help wikipedia expanding httpsenwikipediaorgwikiabarelix